U.S. stocks tumble, investors pause AI rally

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 81 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 53%
  • Publisher: 63%

Nasdaq Composite News

Nvidia,Manufacturing Sector,S&P 500

The benchmark S&P 500 index, Nasdaq and Dow are on track for their biggest daily declines since early August. Shares of chip stocks were hard hit, with AI...

The benchmark S&P 500 index, Nasdaq and Dow are on track for their biggest daily declines since early August. Shares of chip stocks were hard hit, with AI heavyweight Nvidia tumbling nearly 10% and Wall Street's chip index the PHLX chip index slumping 8%.Finland's ruling centre-right coalition plans to spend more on NATO membership, defence and security in 2025, while scaling back on welfare spending to tame the Nordic country's fiscal deficit, it said on Tuesday.

Freshpet is Tuesday's IBD Stock Of The Day, as the IBD 50 member advances above an official buy point amid a 26% surge since hitting recent lows in early August. Freshpet exclusively focuses on "fresh" pet food made with fresh meat, vegetables and fruits. On Aug. 5, Freshpet pared its second-quarter net losses to $1.7 million from $17 million a year ago.The holiday season should be a time of joy, warmth, and good times with family and friends.

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 -- Nkarta, Inc. , a biopharmaceutical company developing engineered natural killer cell therapies, today announced its participation in the following investor conference: H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 10, 202412:30 p.m. ET – fireside chat A simultaneous webcast of each event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archiSOUTH SAN FRANCISCO, Calif.

Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer’s Disease LIFT-AD trial did not meet primary endpoint of GST and key secondary endpoints of cognition and function In pre-specified subgroups of patients with moderate Alzheimer’s disease or who are APOE4 carriers, fosgonimeton showed a numerically greater treatment effect All biomarkers associated with Alzheimer’s disease pathology showed changes with fosgonimeton treatment consistent with the broad neuroprotective mechanism of HGF modulation Athira to host live webcast today atWESTLAKE VILLAGE, Calif.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stock market today: Dow hits record, S&P 500, Nasdaq rise despite fall in Nvidia sharesThe dust is settling after Nvidia's solid but disappointing earnings, as investors reassessed the prospects for techs.
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

Stock market today: Dow closes at record high, S&P 500, Nasdaq slide as tech lagsStocks are eyeing a bid for fresh record highs after Jerome Powell made it crystal clear the Fed is ready to pivot to lowering rates in September.
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

Stock market today: S&P 500, Nasdaq, Dow rise as wait for Powell beginsInvestors are counting down to a speech by Jerome Powell at Jackson Hole that could reset rate-cut expectations.
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

S&P 500, Nasdaq, Dow hold onto gains, Advanced Micro Devices acquires ZT Systems: Yahoo FinanceThe major indexes (^DJI,^GSPC, ^IXIC) are holding onto last week’s gains ahead of Federal Reserve Chair Jerome Powell’s remarks at Jackson Hole later in the ...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »